Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents and patent applications listed in the Supplementary Information section of this notice to MedGene Therapeutics, Inc. ("MedGene"), a company located in Silver Spring, Maryland, the United States of America.
Related coverage
- Administrative Declaration of a Disaster for the State of Colorado
- Television Broadcasting Services Des Moines, Iowa
- Request for Extension of an Information Collection-Local Food Directories and Survey
- Regulations Regarding Payment of Tax by Commercially Acceptable Means
- Approval and Promulgation of Implementation Plans; Arizona; Revisions to the Cleaner Burning Gasoline, Winter Oxygenated Fuel, and Gasoline Set-Aside Programs
- Air Quality Plan; Arizona; Pinal County Air Quality Control District; West Pinal County PM10 Nonattainment Area; Fugitive Dust Rules